Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2006

01-09-2006

Learning Curve for Total Gastrectomy with D2 Lymph Node Dissection: Cumulative Sum Analysis for Qualified Surgery

Authors: Jun Ho Lee, MD, PhD, Keun Won Ryu, MD, Jin-Hee Lee, PhD, Sook Ryun Park, MD, Chan Gyoo Kim, MD, Myoung Cheorl Kook, MD, Byung-Ho Nam, PhD, Young-Woo Kim, MD, Jae-Moon Bae, MD

Published in: Annals of Surgical Oncology | Issue 9/2006

Login to get access

Abstract

Background

This study was conducted to evaluate the leaning curve of D2 lymph node dissection for patients with gastric cancer in a high-volume center.

Methods

The authors prospectively reviewed the data of all patients who underwent total gastrectomy with D2 lymph node dissection during a 4-year period. Retrieved lymph node number was used as a surrogate marker of oncological outcome. The retrieved lymph node number cut-off value required for satisfactory D2 lymph node dissection was defined as >25. Cumulative sum analysis was used to examine the learning curves of individual surgeons at target accuracy rates of 85%, 90%, 92.5%, 95%, and 98%.

Results

Two junior staff surgeons performed 198 curative-intent total gastrectomies with D2 lymph node dissections during the study period; their success rates exceeded 90%. Operating time decreased with operative experience (Pearson correlation coefficient = −0.515, P < 0.001). The learning period for total gastrectomy with D2 lymph node dissection for these two junior members of staff was calculated as 23–35 cases, presuming a 92.5% success rate.

Conclusions

The current study suggests that the surgical learning period for D2 lymph node dissection extends to at least 23 cases or 8 months. In clinical trials containing gastric cancer surgery, the learning curve for qualified surgery from the standpoint of oncological outcome should be considered to minimize bias due to surgeon-associated factors.
Literature
2.
go back to reference Shin HR, Ahn YO, Bae JM, et al. Cancer incidence in Korea. Cancer Res Treat 2002; 34:405–08 Shin HR, Ahn YO, Bae JM, et al. Cancer incidence in Korea. Cancer Res Treat 2002; 34:405–08
3.
go back to reference Schwarz RE, Smith DD. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 2005; 10:5404–05CrossRef Schwarz RE, Smith DD. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 2005; 10:5404–05CrossRef
5.
go back to reference Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000; 87:236–42PubMedCrossRef Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000; 87:236–42PubMedCrossRef
6.
go back to reference Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999; 340:908–14PubMedCrossRef Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999; 340:908–14PubMedCrossRef
7.
go back to reference Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC Randomised Controlled Surgical Trial. The Surgical Cooperative Group. Lancet 1996; 347:995–9PubMedCrossRef Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC Randomised Controlled Surgical Trial. The Surgical Cooperative Group. Lancet 1996; 347:995–9PubMedCrossRef
8.
go back to reference Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345:725–30PubMedCrossRef Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345:725–30PubMedCrossRef
9.
go back to reference Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 2001; 15:3895–902 Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 2001; 15:3895–902
10.
go back to reference Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara, 1–71, 1995 Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara, 1–71, 1995
11.
go back to reference Sobin LH, Wittenkind C. International Union Against Cancer (UICC) TNM Classification of Malignant Tumours, 5th ed. New York: Wiley-Liss, pp 59–62, 1997 Sobin LH, Wittenkind C. International Union Against Cancer (UICC) TNM Classification of Malignant Tumours, 5th ed. New York: Wiley-Liss, pp 59–62, 1997
12.
go back to reference Tekkis PP, Senagore AJ, Delaney CP, et al. Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections. Ann Surg 2005; 242:83–91PubMedCrossRef Tekkis PP, Senagore AJ, Delaney CP, et al. Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections. Ann Surg 2005; 242:83–91PubMedCrossRef
13.
go back to reference Parikh D, Johnson M, Chagla L, et al. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg 1996; 83:1595–9PubMedCrossRef Parikh D, Johnson M, Chagla L, et al. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg 1996; 83:1595–9PubMedCrossRef
14.
go back to reference Wagner PK, Ramaswamy A, Ruschoff J, et al. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991; 78:825–7PubMedCrossRef Wagner PK, Ramaswamy A, Ruschoff J, et al. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991; 78:825–7PubMedCrossRef
15.
go back to reference Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228:449–61PubMedCrossRef Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228:449–61PubMedCrossRef
16.
go back to reference Callahan MA, Christos PJ, Gold HT, et al. Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients. Ann Surg 2003; 238:629–36PubMed Callahan MA, Christos PJ, Gold HT, et al. Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients. Ann Surg 2003; 238:629–36PubMed
17.
go back to reference O’Connor GT, Plume SK, Olmstead EM, et al. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. JAMA 1996; 20:841–6CrossRef O’Connor GT, Plume SK, Olmstead EM, et al. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. JAMA 1996; 20:841–6CrossRef
18.
go back to reference Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol 2000; 18:2327–40PubMed Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol 2000; 18:2327–40PubMed
19.
go back to reference Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 20:1604–08CrossRef Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 20:1604–08CrossRef
20.
go back to reference Dahr DK, Kubota H, Tachbana M, et al. Body mass index determines the success of lymph node dissection and predicts the outcomes of gastric carcinoma patients. Oncology 2000; 59:18–23CrossRef Dahr DK, Kubota H, Tachbana M, et al. Body mass index determines the success of lymph node dissection and predicts the outcomes of gastric carcinoma patients. Oncology 2000; 59:18–23CrossRef
Metadata
Title
Learning Curve for Total Gastrectomy with D2 Lymph Node Dissection: Cumulative Sum Analysis for Qualified Surgery
Authors
Jun Ho Lee, MD, PhD
Keun Won Ryu, MD
Jin-Hee Lee, PhD
Sook Ryun Park, MD
Chan Gyoo Kim, MD
Myoung Cheorl Kook, MD
Byung-Ho Nam, PhD
Young-Woo Kim, MD
Jae-Moon Bae, MD
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 9/2006
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9050-8

Other articles of this Issue 9/2006

Annals of Surgical Oncology 9/2006 Go to the issue